RecruitingPhase 4NCT07308717

Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

1,896 participants

Start Date

Dec 16, 2025

Study Type

INTERVENTIONAL

Conditions

Breast Cancer

Summary

This study aims to assess whether gabapentin should be a standard component of peri-operative pain control in mastectomy patients at Memorial Sloan Kettering Cancer Center.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This trial studies different approaches to managing pain medication (gabapentin) and decision-making after mastectomy surgery to find what works best for patients. **You may be eligible if...** - You are 18–65 years old - You are having an ambulatory extended recovery mastectomy (bilateral or unilateral) at the Josie Robertson Surgical Center **You may NOT be eligible if...** - There are no exclusion criteria for this trial Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.